Clinical Briefings™: Optimizing Cosmetic Outcomes – Advances in Neurotoxic Agents and Biostimulatory Soft Tissue Fillers

Target Audience
This online educational activity is directed toward dermatologists, plastic surgeons, facial plastic surgeons, ocular plastic surgeons, ophthalmologists, and medical professionals from the following disciplines: dermatology, plastic surgery, otolaryngology, ophthalmology, dermatologic surgery, cosmetic surgery, facial plastic surgery, and ocular plastic surgery. It may also be of benefit to nurses in the field of aesthetic medicine and other healthcare providers who are involved in aesthetic medicine.

Program Overview
Facial aging is the result of a combination of changes that involve the skin and underlying tissues. Overall, the changes that result from underlying volume loss and wrinkling associated with age and photodamage can produce a subjectively older appearance. This CME-certified activity entitled, “Clinical Briefings™: Optimizing Cosmetic Outcomes – Advances in Neurotoxic Agents and Biostimulatory Soft Tissue Fillers,” will help physicians select the right tools to optimize outcomes and increase patient satisfaction using a patient-tailored approach.

Learning Objectives
Upon successful completion of this educational activity, you should be better prepared to:

-Explicate the various soft-tissue filler and neurotoxin agents available determined by product characteristics, sites of correction, and safety
-Discuss optimization of cosmetic results through combined approach of neurotoxin and soft-tissue filler therapy
-Discern the clinical impact of recent advances in neurotoxin and soft-tissue filer agents in cosmetic care of patients